• Site Map
  • Contact Us
  • Press Releases
  • Webcasts
  • Events
  • Corporate Fact Sheet
  • Publications
  • Conference and Meeting Presentations

info@opexatherapeutics.com

2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005

News and Resources

2010 Releases

11/08/2022 - Opexa Therapeutics Reports Third Quarter 2010 Financial Results

09/14/2010 - Letter to Shareholders

09/08/2022 - Opexa to Present at the Rodman & Renshaw 12th Annual Healthcare Conference on September 14, 2022

08/09/2022 - Opexa Therapeutics Reports Second Quarter 2010 Financial Results

08/05/2022 - Opexa Reconstitutes Scientific Advisory Board with Industry Leaders

06/07/2022 - Letter to Shareholders

06/03/2022 - Opexa to Prepay Convertible Notes Issued in 2009

05/13/2010 - Opexa Therapeutics Reports First Quarter 2010 Financial Results

05/11/2021 - Opexa Strengthens Tovaxin® Patent Estate Through Issuance of Key Patents

04/27/2010 - Opexa Strengthens Management Team with Hire of Cell Therapy Expert

04/14/2010 - Opexa Presents Tovaxin Data at the American Academy of Neurology 2010 Annual Meeting

04/06/2022 - Opexa to Present Tovaxin Data at the American Academy of Neurology 2010 Annual Meeting

04/01/2022 - Opexa to Participate in Panel Discussion on Personalized Medicine for Multiple Sclerosis

03/05/2022 - Opexa Therapeutics Reports Year End 2009 Financial Results

02/03/2022 - Opexa to Present at the 12th Annual BIO CEO & Investor Conference on February 8, 2022

© 2012 Opexa Therapeutics, Inc. All Rights Reserved.
Privacy PolicyTerms of Use